Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kyoto Medical Planning is a private Japanese medical device company that combines distribution, national agency sales, and in-house research and development. The company manufactures and sells medical devices and biomaterial-based products, including biodegradable stents, absorbable tissue reinforcement materials, and gelatin fiber substrates used for cell culture and regenerative medicine research. Its historical flagship R&D program is the Igaki-Tamai family of bioabsorbable stents, including the REMEDY peripheral biodegradable stent, while its currently marketed product set also includes Genocel and Pawdre. Beyond proprietary products, the company also acts as a regional and national supplier of interventional and hospital devices, especially in cardiovascular care. Overall, Kyoto Medical Planning appears best characterized as a healthcare-focused medical device and biomaterials company rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kyoto Medical Planning.